Skip to content

Added to your cart:

Cart subtotal

View cart (2) Checkout
Antibiotic Medications Bacterial Infection Medicines, Antibiotics & Drugs Fungal Meningitis Treatment Medications Infection Control Nurse Infection Control Products Infection Prevention Products Wound Care Clinic Supplies Wound Care Products
Click or scroll to zoom
Tap or pinch to zoom
Dalbavancin Injection 500 mg Single-Dose Powder Vial
Dalbavancin Injection 500 mg Single-Dose Powder Vial

Dalbavancin Injection 500 mg Single-Dose Powder Vial, Sterile (RX)

by Meitheal Pharmaceuticals
SKU 71288-0034-50
Sale 37%
$ 1,999.95
$ 1,250.00
In stock
Fast Delivery
Fast Delivery
24/7 Support
24/7 Support
Easy Returns
Easy Returns
Hospital Grade
Hospital Grade
Free Shipping on orders above $100
Returns 30-day return / replacement
Payment Secure transaction
Packaging Ships in product packaging
Service-Disabled Veteran-Owned Small Business
Service-Disabled Veteran-Owned Small Business
Located in Adirondack Mountains in NY
Located in Adirondack Mountains in NY
Family Owned Business 2002
Family Owned Business 2002
Sale 37%
$ 1,999.95
$ 1,250.00
Free Shipping on orders above $100
Returns 30-day return / replacement
Payment Secure transaction
Packaging Ships in product packaging
Dalbavancin Injection 500 mg Single-Dose Powder Vial, Sterile (RX)
Dalbavancin Injection 500 mg Single-Dose Powder Vial, Sterile (RX)
$ 1,999.95 $ 1,250.00

Antibiotic Medications

Bacterial Infection Medicines, Antibiotics & Drugs

Fungal Meningitis Treatment Medications

Description

#1 Dalbavancin Injection 500 mg – Sterile Single-Dose Powder Vial | Powerful Antibiotic for Serious Skin Infections | By Meitheal Pharmaceuticals | NDC: 71288-0034-50

Best-in-Class Treatment for Serious Bacterial Infections – Hospital-Grade Dalbavancin 500 mg

Experience next-level infection control with Dalbavancin Injection 500 mg Single-Dose Powder Vial, Sterile by Meitheal Pharmaceuticals. This advanced, FDA-approved antibiotic injection is formulated for the treatment of adult and pediatric patients with acute bacterial skin and skin structure infections (ABSSSI), including life-threatening cand resistant Gram-positive pathogens. Designed for healthcare settings, this sterile powder vial delivers the trusted efficacy, safety, and convenience practitioners demand.

Indications:

  • Cellulitis
  • Abscesses
  • Wound infections
  • Skin and soft tissue infections

How Dalbavancin Stands Out:

  • Long half-life—single or two-dose option
  • Compatible for reconstitution and IV infusion
  • Excellent safety and tolerability
  • Better outcomes for complicated skin infections

⭐ Why Choose Dalbavancin Injection 500 mg by Meitheal Pharmaceuticals?

  • Potent, Once-Weekly IV Antibiotic: Ideal for hospital and outpatient use—provides convenient dosing with just one or two infusions.
  • Broad-Spectrum Gram-Positive Coverage: Highly effective against MRSA, MSSA, Streptococcus pyogenes, and other resistant pathogens causing complicated skin infections.
  • FDA-Approved for ABSSSI: Clinically proven in treating serious skin and soft tissue infections.
  • Sterile Powder Vial for Injection: Ensures maximum stability, purity, and safe reconstitution for intravenous administration.
  • Trusted by Hospitals & Healthcare Systems Nationwide: Manufactured to strict cGMP standards for consistent, reliable clinical results.
  • Minimizes Hospital Stays: Enables outpatient therapy and rapid discharge, helping reduce hospital-acquired infection risks and costs.

Dalbavancin is a cutting-edge, long-acting lipoglycopeptide antibiotic indicated for the treatment of acute bacterial skin and skin structure infections (ABSSSI) in adults and pediatric patients. Its unique pharmacokinetics allow for single or two-dose IV regimens, providing:

  • Rapid and sustained bacterial clearance
  • Superior activity against multidrug-resistant bacteria including MRSA (methicillin-resistant Staphylococcus aureus)
  • Decreased need for prolonged inpatient care or daily infusions
  • Enhanced patient compliance and minimized risk of reinfection

 

Description

#1 Dalbavancin Injection 500 mg – Sterile Single-Dose Powder Vial | Powerful Antibiotic for Serious Skin Infections | By Meitheal Pharmaceuticals | NDC: 71288-0034-50

Best-in-Class Treatment for Serious Bacterial Infections – Hospital-Grade Dalbavancin 500 mg

Experience next-level infection control with Dalbavancin Injection 500 mg Single-Dose Powder Vial, Sterile by Meitheal Pharmaceuticals. This advanced, FDA-approved antibiotic injection is formulated for the treatment of adult and pediatric patients with acute bacterial skin and skin structure infections (ABSSSI), including life-threatening cand resistant Gram-positive pathogens. Designed for healthcare settings, this sterile powder vial delivers the trusted efficacy, safety, and convenience practitioners demand.

Indications:

  • Cellulitis
  • Abscesses
  • Wound infections
  • Skin and soft tissue infections

How Dalbavancin Stands Out:

  • Long half-life—single or two-dose option
  • Compatible for reconstitution and IV infusion
  • Excellent safety and tolerability
  • Better outcomes for complicated skin infections

⭐ Why Choose Dalbavancin Injection 500 mg by Meitheal Pharmaceuticals?

  • Potent, Once-Weekly IV Antibiotic: Ideal for hospital and outpatient use—provides convenient dosing with just one or two infusions.
  • Broad-Spectrum Gram-Positive Coverage: Highly effective against MRSA, MSSA, Streptococcus pyogenes, and other resistant pathogens causing complicated skin infections.
  • FDA-Approved for ABSSSI: Clinically proven in treating serious skin and soft tissue infections.
  • Sterile Powder Vial for Injection: Ensures maximum stability, purity, and safe reconstitution for intravenous administration.
  • Trusted by Hospitals & Healthcare Systems Nationwide: Manufactured to strict cGMP standards for consistent, reliable clinical results.
  • Minimizes Hospital Stays: Enables outpatient therapy and rapid discharge, helping reduce hospital-acquired infection risks and costs.

Dalbavancin is a cutting-edge, long-acting lipoglycopeptide antibiotic indicated for the treatment of acute bacterial skin and skin structure infections (ABSSSI) in adults and pediatric patients. Its unique pharmacokinetics allow for single or two-dose IV regimens, providing:

  • Rapid and sustained bacterial clearance
  • Superior activity against multidrug-resistant bacteria including MRSA (methicillin-resistant Staphylococcus aureus)
  • Decreased need for prolonged inpatient care or daily infusions
  • Enhanced patient compliance and minimized risk of reinfection

 

People Also Searched For

Azithromycin 500mg Tablets Antibiotic 3-Pack (Rx) Azithromycin 250mg Tablets Antibiotic 6-Pack (RX) Amoxicillin Oral Suspension Liquid 125 mg per 5 mL Pediatric Infant & Childrens Antibiotic 100 mL by Sandoz (RX) Amoxicillin 500mg Tablets By Aurobindo Pharma 100/Bottle (Rx) Mupirocin 2% Ointment by Taro Pharmaceuticals 22 gram (Rx) Amoxicillin Oral Suspension Liquid 400 mg per 5 mL Antibiotic 75 mL (RX) Amoxicillin and Clavulanate Potassium 500 mg/125 mg Tablets 20/Bottle (Rx) Amoxicillin 500mg Capsules by Teva 50 Count (RX) Sulfamethoxazole and Trimethoprim 800mg/160 mg Double Strength Tablets 100/Bottle (RX) Azithromycin 250 mg Tablets by Teva Pharma 30 Count (Rx)

Reviewed by 16K+ Customers

4.63 ★ (18089)
Verified

Get Notified When Back in Stock